A guideline-based model described in The Lancet Oncology may provide a new template for high-income and emerging economies to rationally plan and evaluate their cancer surgery provision.
The model replicates examples of benchmarking radiotherapy and chemotherapy demand for cancer surgery across all major site-specific cancers. Investigators suggested the model could be used to identify service gaps at the population level after adjusting to the important local variations in cancer epidemiology.
“The model could also be used to estimate the future demand and the resource requirements for achieving country-specific benchmarks on cancer surgical service provision,” wrote the study authors, who were led by Sathira Kasun Perera, MSc.
In this study, investigators analyzed the latest clinical guidelines from high-income countries and charted surgical treatment pathways for 30 malignant…